Skip to main content
Conavi Medical Corp. logo

Conavi Medical Corp. — Investor Relations & Filings

Ticker · CNVI TSXV Manufacturing
Filings indexed 346 across all filing types
Latest filing 2026-04-23 Regulatory Filings
Country CA Canada
Listing TSXV CNVI

About Conavi Medical Corp.

https://www.conavi.com/

Conavi Medical Corp. is a medical device company focused on designing, manufacturing, and marketing image guidance technologies for minimally invasive cardiovascular procedures. Its flagship product is the Novasight Hybrid System, which provides simultaneous, co-registered Intravascular Ultrasound (IVUS) and Optical Coherence Tomography (OCT) imaging using a single catheter and pullback. This hybrid approach offers comprehensive visualization of coronary arteries, combining the high resolution of OCT for lumen assessment with the depth of IVUS for vessel wall analysis. The system is intended to guide complex Percutaneous Coronary Interventions (PCIs) by providing additional diagnostic information over single-modality imaging.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing an industry award and an FDA 510(k) clearance milestone. It does not present financial results (not an earnings release), does not relate to board changes, capital financing, share transactions, or any annual/interim report, nor does it solicit votes or detail governance rules. It is a general announcement, so it falls into the fallback “Regulatory Filings” category (RNS).
2026-04-23 English
News release - English.pdf
Regulatory Filings Classification · 0% confidence The document is a corporate press release announcing that Conavi Medical received an industry innovation award following FDA 510(k) clearance. It contains forward-looking statements and general company information but does not present financial results, shareholder votes, regulatory filings specific to finances, management changes, or any of the defined categories (e.g., earnings release, interim report, M&A, dividends, etc.). It does not fit any specialized filing and thus falls into the fallback “Regulatory Filings” category (RNS) for miscellaneous announcements.
2026-04-23 English
News release - English.pdf
Regulatory Filings
2026-04-20 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing FDA 510(k) clearance for a new medical device and plans for a commercial launch. It contains no financial results, no voting or dividend information, no management change, no fundraising activity, and no actual report attached or being filed. It is a general regulatory announcement/press release of corporate news that does not fit into any specific specialized category, making “Regulatory Filings (RNS)” the appropriate fallback.
2026-04-20 English
News release - English.pdf
Investor Presentation Classification · 1% confidence The document is a press release announcing that the company’s CEO will present at an upcoming healthcare investor conference, with details on date, time, location, webcast, and replay. It is an investor-facing presentation announcement rather than financial results, regulatory filings, or management changes. This fits the definition of an Investor Presentation (IP).
2026-04-09 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing that the CEO will present at an upcoming investor conference, providing details on timing, location, and webcast. It does not itself contain financial results, a report, or formal proxy materials, nor is it a record of votes, regulatory filing of a financial report, or call transcript. It fits best into the fallback category of general regulatory or investor relations announcements. Therefore, it is classified as RNS.
2026-04-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.